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ina Bissell has never been 
afraid to challenge conventional 
wisdom, whether on a woman’s 
role in the laboratory or on how a cell’s 
context determines its function.
Bissell came to the US from Iran to 
study chemistry at Bryn Mawr and Radcliffe 
Colleges, before pursuing a PhD in bacte-
riology at Harvard Medical School. She 
moved to California for her postdoc in virol-
ogy, before joining the Lawrence Berkeley 
National Laboratory in 1972, where she has 
remained ever since and was the Director of 
all Life Sciences until 2002.
Bissell investigates how the microen-
vironment—particularly the extracellular 
matrix (ECM)—infl  uences cellular behav-
ior. She proposed a “dynamic reciprocity” in 
signals between the ECM and the cell nu-
cleus (1) and, to prove her model, she began 
to study mammary gland biology, devising 
3D culture techniques that 
continue to reveal how dif-
ferentiation is regulated by 
ECM proteins (2, 3). These 
cultures can readily distin-
guish between normal and 
malignant cells (4), and Bis-
sell has shown how breast 
cancer cells can be reverted 
to nonmalignancy by cor-
recting signaling through the 
ECM (5). Moreover, Bissell 
and collaborators have shown that destroy-
ing the ECM with metalloproteinases is suf-
fi  cient to cause tumors (6, 7).
In a recent interview, Bissell helped 
put her own life and career into context.
GROWING UP IN IRAN
Where did your passion for science 
come from?
I was always very curious. I grew up in an 
intellectual and highly educated family, 
and my parents—especially my mother—
were extremely ambitious for us. I read 
voraciously as a kid, and was the top stu-
dent in the country at the end of high 
school. But science wasn’t a passion that I 
grew up with or anybody encouraged me 
to do; it just happened.
Both of my mother’s sisters were in 
the medical profession, and I had a brilliant 
uncle who was a professor at the medical 
school and another who was a math pro-
fessor in the US. My father’s family was 
religious aristocracy: my grandfather was 
an Ayatollah. And his father, grandfather, 
and so on were all Ayatollahs too.
My grandfather was a wonderful, 
scholarly man—I never saw him without 
a book. He had a magnifi  cent library, and 
he wore beautiful long white robes and 
was totally in love with my grandmother all 
his life. He was also the most benevolent 
man I ever met. My father had no inten-
tion of becoming an Ayatollah; he called 
himself an atheist. But he and my grand-
father were the best of friends. It was a 
very different attitude—and version—of 
Islam than people now associate with Iran 
and the current regime.
Do you ever return to Iran?
I haven’t gone back since 
the Shah fell because I’m 
very outspoken and wouldn’t 
tolerate it if someone said, 
“Put that thing on your 
head.” Not once did I have 
to wear even a scarf, de-
spite the fact I had an Ay-
atollah for a grandfather.
The curious thing 
is that even now, 54% of those studying 
engineering, medicine, and architecture 
at universities across Iran are women. 
And 52% of Tehran University faculty are 
women. Who hears about this? All you 
hear is Ahmadinejad!
CHALLENGING EXPECTATIONS
How did you end up in the US?
My father wanted me to go to England—
he felt that America was too young a nation 
and couldn’t train women well. But my 
grandfather said, “If she wants to go to the 
US, then she goes to the US.” And I did!
I had my daughter in the fi  rst year 
of graduate school. It was diffi  cult, 
no question about it, but the idea that I 
would have a child and continue hadn’t 
even occurred to my professors—back 
then there were only three women students 
at Harvard Medical School and just one 
woman faculty. My mom, however, called 
and said, “You’re not quitting, are you? 
Don’t worry, we’ll support you.” I hadn’t 
even thought once about giving up!
You enjoy challenging conventional 
wisdom in science. Has that always 
been the case?
As a child, I was encouraged to speak up. 
After four years of graduate school, I dis-
covered that the whole basis of my project 
was wrong. When I told my professor, he 
replied “You won’t make it as a scientist!” 
I went home and cried, but from then on I 
knew that I’d stay in science. He became 
a believer and a friend as soon as I showed 
him more proof.
I moved to California with my hus-
band and after two years of postdoctoral 
work, I got a job in the empire of Melvin 
Calvin at UC Berkeley. He was a real 
dictator—I was being fi  red every week 
because I showed up pregnant with my 
second child. His associates always had 
to calm him down. One day I looked him 
in the eye and said, “I disagree with you 
sometimes, but not because I’m being dif-
fi  cult. You know so much more than I do, 
but I just know a bit more about biology, 
so why be so angry all the time?” He was 
totally surprised—nobody had ever said 
anything like that to him before—and we 
not only ended up being close colleagues, 
he also became one of my champions.
Bissell remains as passionate about science as ever.
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How can the funding system help 
people develop unconventional ideas?
I always say, “If you have an original idea or 
you’re really making a huge jump, you 
should expect not to get funded. If you do, it 
means people already largely understand 
it.” But there has to be room for people to do 
long-term challenging work.
NIH is becoming more adventurous 
now, but I couldn’t get NIH money for 15 
years; thankfully I get funded now. NSF 
gave me my fi  rst grant, and without the 
DOE Offi   ce of Biological and Environ-
mental Research, who decided early on 
I had something important to 
say, I would have had to give 
up some of my radical ideas. 
One needs alternative sources 
of funds: the breast cancer 
program in the Department 
of Defense has been creative 
and refreshing despite some 
initial criticism.
But fi  nding these alter-
natives is becoming harder 
and harder because doing 
something novel in biology these days is so 
darn complex: You need lots of money and 
collaborations. One person with a microscope 
can rarely make a huge discovery now.
How does that affect universities?
They need drastic reforms too. Decisions on 
tenure should assess the total impact of your 
work, and not whether you were the only 
one who intellectually contributed to it—
you can’t insist that people do it alone. Ad-
ditionally, I think professors shouldn’t keep 
their tenure after 65. Younger people need 
these jobs and we need to share resources. If 
you’re still really passionate and capable of 
getting money after 65, then you should be 
given laboratory space and allowed to con-
tinue but, if not, you should work with and 
help younger group leaders instead.
So it’s important for younger 
scientists to come through?
Yes, but we’re all told in graduate school 
that everybody has to be a professor or 
they’re a failure, which is nonsense. A 
few years ago there was a movement to 
limit the number of PhDs, but I think that 
was wrong. People who want to be edu-
cated should be, and then they can decide 
what to do with that education.
If people aren’t passionate and a 
little nutty about science, they shouldn’t 
continue with research. I agree with Bruce 
Alberts that PhDs can, and should, con-
tribute to society and to science in many 
different ways.
UNDERSTANDING COMPLEXITY
You’re involved with a new journal: 
Integrative Biology. What’s the concept 
behind it?
I’ve always been enamored 
with technologies that push 
biology forward, and I’ve 
always known that we 
wouldn’t understand com-
plex biological questions 
without bringing different 
fi  elds together. I was asked 
by the Royal Society of 
Chemistry to chair the jour-
nal’s editorial board and I 
said, “Fine, but only if we 
insist on novel technologies that really 
answer important biological problems.”
One of my current fellows devel-
oped a microenvironmental array to study 
the fate of breast progenitor cells. The 
reviewers lost sight of the importance of 
the technology and kept saying, “Why 
didn’t you work in a mouse? You should 
make a mouse.” So we put this beautiful 
paper in the fi  rst issue of iBiology. You 
can’t answer every question in a mouse, 
especially when you want to work with 
human cells! Nature is so clever, if you 
knock a gene out, something different 
happens. It’s not just redundancy—the 
complexity makes it very diffi  cult for us 
to know what’s going on. So you need 
a combination of model systems. This is 
why I appreciated early on that we needed 
to develop physiological assays.
Why are 3D approaches so important?
Studies with 3T3 and HeLa cells were 
useful in discovering new genes and proc-
esses. But you can’t understand tissue 
specifi  city in 2D cultures, and you can’t 
always do it in the mouse. 3D cultures are 
not always physiological either. To work 
outside the animal, you have to create a 
situation where the context tells the cell 
that it’s a particular tissue and not some-
thing else. I always quote Gloria Heppner 
[from Wayne State University in Detroit]: 
“Don’t ask what a cell can do, ask what it 
does do!”
We recently showed in 3D cultures 
that an ECM protein, laminin-111, must 
continuously signal to the chromatin for 
a mammary cell to express milk proteins. 
It would be really diffi  cult to study this 
in vivo—you can’t follow the kinetics. So 
we go back and forth between the mouse 
and physiological 3D cultures.
Finally, imaging is extremely im-
portant. Differentiation is dynamic and 
reciprocal; without imaging cells in 3D 
culture and in vivo, you won’t learn 
what allows a mammary cell to be a 
mammary cell. I always say that there’s 
no reason for arrogance because we still 
know so little. We’ve discovered a lot, 
but there’s still so much to learn; and 
it’s so much fun!
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Breast cells cultured in 3D reproduce the 
structural units—acini—of human breast.
“If people 
aren’t 
passionate and 
a little nutty 
about science, 
they shouldn’t 
continue.”